ArticleFrontiers in pharmacology2022

TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway.

Zeyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.